Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 3—March 2026

Research

Strongyloides Genetic Diversity among Humans, Dogs, and Nonhuman Primates, Central African Republic, 2016–2022

Eva Nosková, Vladislav Ilík, Frédéric Stéphane Singa Niatou, Laurent Dumas, Terence Fuh, Jean-Francais Dicky, Terézia Kurucová, Vojtech Baláž, Klára Judita Petrželková, and Barbora PafčoComments to Author 
Author affiliation: Masaryk University, Brno, Czech Republic (E. Nosková, V. Ilík, B. Pafčo); Masaryk University, Central European Institute of Technology, Brno (T. Kurucová); Czech Academy of Sciences, Institute of Vertebrate Biology, Brno (E. Nosková, V. Ilík, K.J. Petrželková, B. Pafčo); Czech Academy of Sciences, Biology Center, Institute of Parasitology, Ceske Budejovice, Czech Republic (K.J. Petrželková); WWF Central African Republic Programme Office, Dzanga Sangha Protected Areas, Bangui, Central African Republic (F.S. Singa Niatou, T. Fuh); Toulouse National School of Veterinarians, Toulouse, France (L. Dumas); University of Veterinary Sciences, Brno (V. Baláž)

Main Article

Table

Prevalence of individual Strongyloides hypervariable region IV 18S rRNA haplotypes assessed from quantitative PCR–positive samples across host species in study of Strongyloides genetic diversity, Central African Republic, 2016–2022

Haplotype No. (%)
Humans, n = 38 Dogs, n = 28 Gorillas, n = 58 Chimpanzees, n = 3 Mangabeys, n = 16
S. stercoralis A 28 (73.7) 7 (25) 7 (12.1) 0 0
S. fuelleborni K 9 (23.7) 6 (21.4) 4 (6.9) 0 0
S. fuelleborni L 38 (100) 26 (92.8) 54 (93.1) 3 (100) 13 (81.3)
S. fuelleborni M 7 (18.4) 9 (32.1) 0 0 0
S. fuelleborni P 1 (2.6) 1 (3.6) 38 (65.5) 3 (100) 10 (62.5)
S. fuelleborni T 1 (2.6) 0 0 0 0
S. fuelleborni unclassified 2 (5.3) 3 (10.7) 2 (3.4) 0 2 (12.5)
Strongyloides unclassified 3 (7.9) 4 (14.3) 3 (5.2) 0 4 (25)

Main Article

Page created: February 07, 2026
Page updated: March 20, 2026
Page reviewed: March 20, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external